Literature DB >> 30644014

Childhood Hodgkin Lymphoma: Think DADA2.

Fahad Alabbas1,2, Ghaleb Elyamany3,4, Omar Alsharif5, Michael Hershfield6, Isabelle Meyts7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30644014     DOI： 10.1007/s10875-019-0590-7

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN： 0271-9142            Impact factor:   8.317


× No keyword cloud information.
  18 in total

1.  Early-onset stroke and vasculopathy associated with mutations in ADA2.

Authors:  Qing Zhou; Dan Yang; Amanda K Ombrello; Andrey V Zavialov; Camilo Toro; Anton V Zavialov; Deborah L Stone; Jae Jin Chae; Sergio D Rosenzweig; Kevin Bishop; Karyl S Barron; Hye Sun Kuehn; Patrycja Hoffmann; Alejandra Negro; Wanxia L Tsai; Edward W Cowen; Wuhong Pei; Joshua D Milner; Christopher Silvin; Theo Heller; David T Chin; Nicholas J Patronas; John S Barber; Chyi-Chia R Lee; Geryl M Wood; Alexander Ling; Susan J Kelly; David E Kleiner; James C Mullikin; Nancy J Ganson; Heidi H Kong; Sophie Hambleton; Fabio Candotti; Martha M Quezado; Katherine R Calvo; Hawwa Alao; Beverly K Barham; Anne Jones; James F Meschia; Bradford B Worrall; Scott E Kasner; Stephen S Rich; Raphaela Goldbach-Mansky; Mario Abinun; Elizabeth Chalom; Alisa C Gotte; Marilynn Punaro; Virginia Pascual; James W Verbsky; Troy R Torgerson; Nora G Singer; Timothy R Gershon; Seza Ozen; Omer Karadag; Thomas A Fleisher; Elaine F Remmers; Shawn M Burgess; Susan L Moir; Massimo Gadina; Raman Sood; Michael S Hershfield; Manfred Boehm; Daniel L Kastner; Ivona Aksentijevich
Journal:  N Engl J Med       Date:  2014-02-19       Impact factor: 91.245

2.  ADA2 Deficiency Mimicking Idiopathic Multicentric Castleman Disease.

Authors:  Erika Van Nieuwenhove; Stephanie Humblet-Baron; Lien Van Eyck; Lien De Somer; James Dooley; Thomas Tousseyn; Michael Hershfield; Adrian Liston; Carine Wouters
Journal:  Pediatrics       Date:  2018-09       Impact factor: 7.124

3.  Deficiency of ADA2 mimicking autoimmune lymphoproliferative syndrome in the absence of livedo reticularis and vasculitis.

Authors:  Abdulrahman Alsultan; Enas Basher; Jubran Alqanatish; Reem Mohammed; Majid Alfadhel
Journal:  Pediatr Blood Cancer       Date:  2017-12-22       Impact factor: 3.167

4.  ADA2 deficiency: Clonal lymphoproliferation in a subset of patients.

Authors:  Luca Trotta; Timi Martelius; Timo Siitonen; Timo Hautala; Sari Hämäläinen; Hanna Juntti; Mervi Taskinen; Mette Ilander; Emma Irene Andersson; Andrey Zavialov; Meri Kaustio; Riikka Keski-Filppula; Michael Hershfield; Satu Mustjoki; Terhi Tapiainen; Mikko Seppänen; Janna Saarela
Journal:  J Allergy Clin Immunol       Date:  2018-01-31       Impact factor: 10.793

5.  ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national study.

Authors:  Roberta Caorsi; Federica Penco; Alice Grossi; Antonella Insalaco; Alessia Omenetti; Maria Alessio; Giovanni Conti; Federico Marchetti; Paolo Picco; Alberto Tommasini; Silvana Martino; Clara Malattia; Romina Gallizi; Rosa Anna Podda; Annalisa Salis; Fernanda Falcini; Francesca Schena; Francesca Garbarino; Alessia Morreale; Manuela Pardeo; Claudia Ventrici; Chiara Passarelli; Qing Zhou; Mariasavina Severino; Carlo Gandolfo; Gianluca Damonte; Alberto Martini; Angelo Ravelli; Ivona Aksentijevich; Isabella Ceccherini; Marco Gattorno
Journal:  Ann Rheum Dis       Date:  2017-05-18       Impact factor: 19.103

6.  Phenotypic variability in patients with ADA2 deficiency due to identical homozygous R169Q mutations.

Authors:  Joris M Van Montfrans; Esther A R Hartman; Kees P J Braun; Eric A M Hennekam; Elisabeth A Hak; Paul J Nederkoorn; Willeke F Westendorp; Robbert G M Bredius; Wouter J W Kollen; Elisabeth H Schölvinck; G Elizabeth Legger; Isabelle Meyts; Adrian Liston; Klaske D Lichtenbelt; Jacques C Giltay; Gijs Van Haaften; Gaby M De Vries Simons; Helen Leavis; Cornelis J G Sanders; Marc B Bierings; Stefan Nierkens; Marielle E Van Gijn
Journal:  Rheumatology (Oxford)       Date:  2016-02-10       Impact factor: 7.580

7.  Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy.

Authors:  Paulina Navon Elkan; Sarah B Pierce; Reeval Segel; Tom Walsh; Judith Barash; Shai Padeh; Abraham Zlotogorski; Yackov Berkun; Joseph J Press; Masha Mukamel; Isabel Voth; Philip J Hashkes; Liora Harel; Vered Hoffer; Eduard Ling; Fatos Yalcinkaya; Ozgur Kasapcopur; Ming K Lee; Rachel E Klevit; Paul Renbaum; Ariella Weinberg-Shukron; Elif F Sener; Barbara Schormair; Sharon Zeligson; Dina Marek-Yagel; Tim M Strom; Mordechai Shohat; Amihood Singer; Alan Rubinow; Elon Pras; Juliane Winkelmann; Mustafa Tekin; Yair Anikster; Mary-Claire King; Ephrat Levy-Lahad
Journal:  N Engl J Med       Date:  2014-02-19       Impact factor: 91.245

8.  IL-17 receptor A and adenosine deaminase 2 deficiency in siblings with recurrent infections and chronic inflammation.

Authors:  Florence Fellmann; Federica Angelini; Jacqueline Wassenberg; Matthieu Perreau; Natalia Arenas Ramirez; Gregoire Simon; Onur Boyman; Olivier Demaria; Stephanie Christen-Zaech; Daniel Hohl; Marco Belfiore; Annette von Scheven-Gete; Michel Gilliet; Pierre-Yves Bochud; Yannick Perrin; Maya Beck Popovic; Pierre-Alexandre Bart; Jacques S Beckmann; Danielle Martinet; Michaël Hofer
Journal:  J Allergy Clin Immunol       Date:  2015-11-20       Impact factor: 10.793

9.  Warts and DADA2: a Mere Coincidence?

Authors:  Katrijn Arts; Jenna R E Bergerson; Amanda K Ombrello; Morgan Similuk; Andrew J Oler; Anahita Agharahimi; Emily M Mace; Mike Hershfield; Carine Wouters; Lien De Somer; Marie-Anne Morren; Rebeca Perez-de Diego; Leen Moens; Alexandra F Freeman; Isabelle Meyts
Journal:  J Clin Immunol       Date:  2018-11-01       Impact factor: 8.542

Review 10.  Deficiency of Adenosine Deaminase 2 (DADA2): Updates on the Phenotype, Genetics, Pathogenesis, and Treatment.

Authors:  Isabelle Meyts; Ivona Aksentijevich
Journal:  J Clin Immunol       Date:  2018-06-27       Impact factor: 8.317
View more
  9 in total

1.  Genotype and Phenotype of Adenosine Deaminase 2 Deficiency: a Report from Saudi Arabia.

Authors:  Fahad Alabbas; Talal Alanzi; Abdulrahman Alrasheed; Mohammed Essa; Ghaleb Elyamany; Abdulrahman Asiri; Sajdi Almutairi; Sulaiman Al-Mayouf; Abdullatif Alenazi; Danyah Alsafadi; Walid Ballourah; Naif Albalawi; Ehab Hanafy; Abdulqader Al-Hebshi; Seham Alrashidi; Fatma Albatniji; Huda Alfaraidi; Tahani Bin Ali; Mansour Al Qwaiee; Maryam AlHilali; Hayam Aldeeb; Ali Alhaidey; Hassan Aljasem; Sami Althubaiti; Abdulrahman Alsultan
Journal:  J Clin Immunol       Date:  2022-10-14       Impact factor: 8.542

Review 2.  Deficiency of Human Adenosine Deaminase Type 2 - A Diagnostic Conundrum for the Hematologist.

Authors:  Rakesh Kumar Pilania; Aaqib Zaffar Banday; Saniya Sharma; Rajni Kumrah; Vibhu Joshi; Sathish Loganathan; Manpreet Dhaliwal; Ankur Kumar Jindal; Pandiarajan Vignesh; Deepti Suri; Amit Rawat; Surjit Singh
Journal:  Front Immunol       Date:  2022-05-03       Impact factor: 8.786

Review 3.  Lymphoproliferation in Inborn Errors of Immunity: The Eye Does Not See What the Mind Does Not Know.

Authors:  Saniya Sharma; Rakesh Kumar Pilania; Gummadi Anjani; Murugan Sudhakar; Kanika Arora; Rahul Tyagi; Manpreet Dhaliwal; Pandiarajan Vignesh; Amit Rawat; Surjit Singh
Journal:  Front Immunol       Date:  2022-05-04       Impact factor: 8.786

Review 4.  Expanding spectrum of DADA2: a review of phenotypes, genetics, pathogenesis and treatment.

Authors:  Benzeeta Pinto; Prateek Deo; Susmita Sharma; Arshi Syal; Aman Sharma
Journal:  Clin Rheumatol       Date:  2021-03-31       Impact factor: 2.980

5.  Intrinsic Defects in B Cell Development and Differentiation, T Cell Exhaustion and Altered Unconventional T Cell Generation Characterize Human Adenosine Deaminase Type 2 Deficiency.

Authors:  Stuart G Tangye; Isabelle Meyts; Jin Yan Yap; Leen Moens; Ming-Wei Lin; Alisa Kane; Anthony Kelleher; Catherine Toong; Kathy H C Wu; William A Sewell; Tri Giang Phan; Georgina E Hollway; Karen Enthoven; Paul E Gray; Jose Casas-Martin; Carine Wouters; Lien De Somer; Michael Hershfield; Giorgia Bucciol; Selket Delafontaine; Cindy S Ma
Journal:  J Clin Immunol       Date:  2021-10-17       Impact factor: 8.317

6.  Novel Adenosine Deaminase 2 (ADA2) Mutations Associated With Hematological Manifestations.

Authors:  Reem Albalawi; Ehab Hanafy; Haifa Alnafea; Mohammed Altowijiry; Shaima Riyad; Fadwa Abufara; Naif Albolowi
Journal:  J Investig Med High Impact Case Rep       Date:  2021 Jan-Dec

Review 7.  Allogeneic Hematopoietic Cell Transplantation for Patients With Deficiency of Adenosine Deaminase 2 (DADA2): Approaches, Obstacles and Special Considerations.

Authors:  Hasan Hashem; Dimana Dimitrova; Isabelle Meyts
Journal:  Front Immunol       Date:  2022-07-07       Impact factor: 8.786

Review 8.  The Many Faces of a Monogenic Autoinflammatory Disease: Adenosine Deaminase 2 Deficiency.

Authors:  Jennifer Lee Kendall; Jason Michael Springer
Journal:  Curr Rheumatol Rep       Date:  2020-08-26       Impact factor: 4.592

9.  Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients.

Authors:  Hasan Hashem; Giorgia Bucciol; Seza Ozen; Sule Unal; Ikbal Ok Bozkaya; Nurten Akarsu; Mervi Taskinen; Minna Koskenvuo; Janna Saarela; Dimana Dimitrova; Dennis D Hickstein; Amy P Hsu; Steven M Holland; Robert Krance; Ghadir Sasa; Ashish R Kumar; Ingo Müller; Monica Abreu de Sousa; Selket Delafontaine; Leen Moens; Florian Babor; Federica Barzaghi; Maria Pia Cicalese; Robbert Bredius; Joris van Montfrans; Valentina Baretta; Simone Cesaro; Polina Stepensky; Neven Benedicte; Despina Moshous; Guillaume Le Guenno; David Boutboul; Jignesh Dalal; Joel P Brooks; Elif Dokmeci; Jasmeen Dara; Carrie L Lucas; Sophie Hambleton; Keith Wilson; Stephen Jolles; Yener Koc; Tayfun Güngör; Caroline Schnider; Fabio Candotti; Sandra Steinmann; Ansgar Schulz; Chip Chambers; Michael Hershfield; Amanda Ombrello; Jennifer A Kanakry; Isabelle Meyts
Journal:  J Clin Immunol       Date:  2021-07-29       Impact factor: 8.542
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.